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Towards the Electrochemical Diagnostic 
of Influenza Virus: Development of 
Graphene-Au Hybrid Nanocomposite 
Modified Influenza Virus Biosensor 
Based on Neuraminidase Activity 
 
Ülkü Anik*
a
,  Yudum Tepeli
a
, Maher Sayhi
b,c
, Jihene Nsiri
b
, 
Mohamed Fethi Diouani*
b 
An effective electrochemical influenza A biosensor based on graphene-
gold (Au) hybrid nanocomposite modified Au-screen printed electrode 
has been developed. The working principle of the developed biosensor 
relies on the measurement of neuraminidase (N) activity. After the 
optimization of experimental parameters like the effect of bovine serum 
albumin addition, immobilization time of fetuin A and immobilization 
time of PNA lectin, the analytical characteristics of the influenza A 
biosensor were investigated. As a result, a linear range between 10
-8
 
U/mL and 10
-1
 U/mL has been found with relative standard deviation 
value of 3.23% (for 10
-5
 U/mL of N, n:3) and limit of detection value as 10
-
8
 U/mL N .The developed biosensor has also been applied for real 
influenza virus A (H9N2) detection and very successful results were 
obtained. 
Introduction 
Influenza virus A can be described as  a negative stranded 
RNA virus which belongs to Orthomyxoviridae family. The 
virus contains two surface glycoproteins namely 
hemagglutinin (H) and neuraminidase (N). The classification 
of the virus subtype can be made according to the antigenic 
properties of these 18 H (1−18) and 11 N (1−11) 
glycoproteins
1-14
. Since the influenza virus is very mutagenic, 
it can easily change the antigenic portions of H and N 
proteins and as a result very serious antigenic drift has been 
occurred 
15
. Seasonal influenza viruses can easily be affected 
by these antigenic drift mutations which cause millions of 
serious infections and approximately 500.000 deaths for 
every year 
15,16
. Also, sometimes two or more influenza A 
viruses of different origin infects the same cell and as a 
result, new strains or subtypes are emerged because of the 
occurrence of genetic reassortment 
1
. As an example, the 
reassortment between human and avian virus strains was 
the reason of influenza A pandemics in 1957 (H2N2) and in 
1968 (H3N2) while in 2009 (H1N1) pandemic virus was 
found to be a reassortant containing gene segments from 
human, avian and swine influenza viruses 
2,4
. Besides these, 
highly mortal avian viruses like H5N1 and H7N9 have been 
discovered to transmit from birds to humans 
4, 17
. Because of 
these, some researchers define the virus as “continuously 
emerging infectious disease” which means it still continues 
to be a threat for animals and human beings 
15
. 
Although rapid detection of this virus is mandatory, present 
influenza diagnosis techniques cannot compete with the 
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mutagenic behavior of the influenza virus. For example, viral 
culture, which was accepted as a golden standard method, 
needs two or three days to retrieve the results which is a 
kind of long time for the diagnosis of influenza virus 
18-20
. On 
the other hand, quantitative polymerase chain reaction 
(qPCR), which is chosen frequently by the health personnel 
can be described as sensitive but relatively slow (took about 
2 h). qPCR is also expensive and can be performed only with 
the specialists 
20-22
. Apart from these methods, various 
immune based rapid tests have been fabricated recently to 
compensate the fast diagnosis need of the virus. From this 
point of view, these tests manage to show  the results in 15 
to 30 min. However, on the other hand, they lack off the 
sensitivity and the precision 
20, 21, 23, 24
. 
Electrochemical techniques are accepted as practical 
techniques for many applications
25, 26
. The combination of 
electrochemical techniques with biosensor systems, results 
with electrochemical biosensors which provide not only 
practicality but selectivity and sensitivity as well 
27, 28
. For 
these reasons, electrochemical biosensors can be accepted 
as good candidates to be used in point of care systems 
29
. 
Recently electrochemical biosensors were combined with 
nanomaterials and as a result, more sensitive and accurate 
results were obtained 
30-32
. Graphene is a kind of two-
dimensional nanomaterial and provides properties like 
higher surface area and good conductivity which are very 
important for the electrochemical biosensors 
33-35
. Apart 
from graphene, recently graphene-metallic nanocomposites 
were produced and used in these systems. These 
nanocomposites provide more sensitive and selective 
results when combined with the biosensor systems 
36-43
  
Considering the influenza biosensors, it can be stated that, 
up to now almost only H based systems have been 
developed 
7-10, 44-48
. Lately our group managed to develop a 
N based electrochemical influenza biosensor 
14
. In that 
work, as a preliminary data, only the electrochemical 
impedance spectroscopy (EIS) diagrams about the 
fabrication of biosensor were presented 
14
. For that earlier 
work, glassy carbon paste electrode was used as the main 
electrode. Firstly fetuin A that is a kind of glycoprotein was 
attached onto the electrode. Then, N was immobilized onto 
fetuin A. Fetuin A includes terminal 12-14 sialic acid residues 
per molecule and N clevages fetuin A from this sialic acid 
ends. Lastly, peanut agglutinin (PNA) lectin was immobilized 
onto the electrode surface to monitor this cleavage 
14
.
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In this work, as a continuation of our previous paper, we 
improve our system by using gold screen printed electrode 
(AuSPE) together with graphene-Au hybrid nanocomposite. 
Also the experimental parameters about the developed system 
were optimized and analytical characteristics were examined. 
Lastly, the developed biosensor was applied for real influenza 
A virus (H9N2) detection.  
Experimental 
 
Chemicals 
Graphite powder, NaNO3, chloroauric acid (HAuCl4.H2O), 
K3[Fe(CN)6], K4[Fe(CN)6].3H2O, N-(3-Dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC), N-Hydroxysuccinimide 
(NHS), fetuin A, bovine serum albumin (BSA), N, PNA lectin, 
MES monohydrate and ethylene glycol (EG) were purchased 
from Sigma-Aldrich. H2SO4, H2O2, KMnO4, KH2PO4, NaOH, NaCl 
and KCl were obtained from Merck. Double distilled water was 
used for the preparation of all solutions. All chemicals were of 
analytical grade and were used without needing further 
purification. 
 
Instrumentation 
Electrochemical measurements were carried out by using μ-
AUTOLAB Type III with the FRA 2 module electrochemical 
measurement system from Metrohm B.V. that is controlled by 
NOVA 1.10 software.  AuSPE was used as a working electrode 
and was purchased from Dropsens. SEM and EDS 
measurements were performed at JSM-7600 F FEG-SEM at 
15.0 kV. During the preparation procedure of graphene-Au 
nanocomposite, Thermo Electron Corporation as pH-meter, 
IKA ® C-MAG HS7 hotplate, Bandelin Sonorex sonicator and 
NUVE vacuum oven were used. For the incubation of biological 
materials at 37
o
C incubator shaker was used.   ELLA 
measurements were carried out with Automatic plate reader 
with 490nm filter. 
Synthesis procedure of graphene-Au nanocomposite 
In order to synthesize graphene-Au nanocomposite, graphene 
oxide (GO) was used as the starting material. Therefore, first 
GO was synthesized by using modified Hummers-Offeman 
method from graphite 
38, 49
. For this purpose, 1g of graphite 
powder was added into 23 mL 98% H2SO4 solution and stirred 
at room temperature for 24 h. Then, 100 mg of NaNO3 was 
added into the mixture and stirred for another 30 min. After 
the mixture was cooled to 5 
o
C by using an ice-bath, 3 mg of 
KMnO4 was added to the medium and then the stirred mixture 
was heated up to 40 
o
C. 46 mL of double distilled water was 
added into above mixture during a period of 25 min. Finally, 
140 mL of double distilled water and 10 mL of 30% H2O2 were 
added into the mixture to stop the reaction. The unexploited 
graphite in the resulting mixture was removed by 
centrifugation. Then the mixture was dried in a desiccator at 
room temperature. 
Additionally, for the graphene-Au nanocomposite synthesis 
step, 10 mg portion of GO powder which was synthesized by 
modified Hummers-Offeman method was dispersed in 10 mL 
of water by sonication for 1 h to form stable GO colloid 
50, 51
. 
Then, 20 mL of EG solution and 0.5 mL of 0.01 M HAuCl4.H2O 
were added to the GO colloid and stirred for 30 min. After 
that, the mixture was heated at 100 
o
C for 6 h by applying the 
magnetic stirring. Subsequently, the graphene-Au 
nanocomposites were separated from the EG solution via 
centrifugation and washed with deionized water for five times. 
The resulting product was dried in a vacuum oven at 60 
o
C for 
12 h
37
. Finally, the synthesized graphene-Au nanocompsite 
was dispersed to 10 mg/mL in double distilled water by 
ultrasonication and stored at 4 
o
C until it was used 
38, 40, 41, 52
. 
Preparation of developed electrochemical Influenza A biosensor 
AuSPE was used as the supporting electrode for the 
preparation of developed electrochemical influenza A 
biosensor. First, AuSPE was modified with graphene-Au hybrid 
nanocomposite. For this purpose, 6 µL of graphene-Au 
nanocomposite dispersion (10 mg/mL, in double distilled 
water) was dropped onto the surface of AuSPE and dried at 
room temperature for 1h. Then, 10 μL of  50 mM EDC/NHS 
mixture (in 50 mM MES pH:5.5 solution) was dropped onto the 
electrode surface and waited for 1h. Subsequently, the 
electrode surface was rinsed with MES and phosphate 
buffered saline (PBS) with pH value of 7.4 (137 mM NaCl, 10 
mM KH2PO4, and 2.7 mM KCl). After that, 10 μL of 250 μg/250 
μL of fetuin A in 0.1 M PBS was immobilized onto the electrode 
surface and waited for 30 min. The electrode surface was then 
washed with PBS and then 10 μL of  1% BSA (in 0.1 PBS) 
solution was dropped on to electrode surface for performing 
BSA effect experiments. Other than that, BSA was not used 
during the fabrication of the influenza A virus biosensor. After 
that, the electrode was rinsed with PBS and 10 μL of different 
concentrations of  N (in 0.1 M pH:7.4 PBS) was dropped onto 
the electrode surface and waited for 18 h at 37 
o
C under the 
stirring. After the electrode surface was washed with PBS, 10 
μL of 50 μg/mL PNA lectin (in 0.1 M pH:7.4 PBS) solution was 
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dropped onto the developed electrochemical biosensor for 1 h 
at +4 
o
C. PNA lectin here specifically binds to the galactose 
molecules that appear after N cleavages the sialic acids from 
fetuin A molecule. By this way, N activity of the developed 
influenza A biosensor was determined electrochemically 
(Scheme 1). The characterization of the developed 
electrochemical influenza A biosensor and the determination 
of N activity studies were carried out by using EIS method. 
 
 Scheme 1. Schematic diagram depicting the steps of developed 
electrochemical influenza A biosensor. 
Influenza type A virus replication in embryonated eggs 
H9N2 influenza type A virus (A/Equi/1/Prague 56) was 
propagated in 11- day old specific-pathogen free (SPF) chicken 
embryonated eggs via the allantoic route. The eggs were 
incubated at 37 °C for three days and the allantoic fluid was 
collected, clarified by centrifugation at 3000xg for 15 min. Viral 
titer, in the collected allontoic fluids, was monitored by 
hemagglutination test. 
ELLA measurements 
An Enzyme-Linked Lectin Assay (ELLA) was performed to 
measure influenza A virus N activity as described by Couzens, 
L. et al. 
3
. Fetuin-coated plate was prepared by dispense 
100µl/well of 25µg/ml fetuin working solution into each well. 
The plate was covered and placed at +4°C for 24hours. Then, 
the plate was washed 3 times with 200µl/well PBS wash buffer 
for 3 minutes. 100µl sample diluent buffer was added in 
column 12 as negative control and 50µl serial dilution antigen 
(influenza virus, N and non-infected allontoic fluid) was 
transferred from the dilution plate to each well in column 1-11 
of the fetuin-coated plate contain an equal volume of sample 
diluent buffer. The plate was incubated in humidified 
incubator with 5% CO2 for 18hours at 37°C, and then washed 6 
times as described before. 100µl/well PNA-peroxidase was 
dispensed into each well and incubated at room temperature 
for 2 hours. After this step, 3 times wash was performed 
before adding of 100µl/well freshly prepared substrate 
solution for 10 min in dark at room temperature. The color 
reaction was stopped by the addition of 100µl/well stop 
solution. The plates were read at 490 nm using 96-well 
Automatic plate reader. 
 
 
Results and Discussion 
Characterization of synthesized graphene-Au hybrid 
nanocomposite 
Fig. 1 demonstrates the SEM images and EDS results of 
graphene-Au nanocomposite. It can be seen from the Fig. 1 
that AuNps are located on the graphene sheets as white dots 
(average diameter of 250 nm). EDS results show that atomic 
dispersion percentages of graphene-Au nanocomposite are 
83.73 %, 14.97 % ,1.06 % and mass percentages of these 
elements 69.29%, 14.66% and 14.32% for C, O and Au, 
respectively. 
 
 
Figure 1. A), B) SEM images of graphene-Au nanocomposite 
and C) EDS results of graphene-Au nanocomposite. 
Electrochemical characterization of developed 
electrochemical Influenza A biosensor 
 The fabrication of developed influenza A biosensor was 
monitored via EIS in the presence of 10 mM 
K3[Fe(CN)6]/K4[Fe(CN)6]. From the Nyquist plots of EIS (Fig. 2); 
it can be seen that bare AuSPE has the small semi-circle 
domain because of high conductivity of Au surface (curve a).  
After the electrode modification with graphene-Au hybrid 
nanocomposite, semi-circle domain increases a little bit (curve 
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b). After that, when the electrode surface was covered with 
fetuin A, the resistance of the electrode surface increases since 
active surface area was blocked (curve c). Then, N was 
immobilized on to fetuin A from the sialic acid sides. 
Therefore, electrode surface was covered with N and charge 
transfer ability of the electrode surface was reduced resulting 
with the increment in the semicircle diameter (curve d). Lastly, 
PNA lectin which has specificity to galactose molecules that 
appears after the cleavage of fetuin A with N, was used. When 
the PNA lectin binds onto the galactose molecules, the 
electron transfer was getting even harder and semi-circle 
diameter also increases due to the resistance increase on the 
electrode surface (curve e). 
 Optimization of Experimental Parameters  
The experimental parameters consisting of the effect of BSA 
addition on developed system, immobilization time of fetuin A, 
immobilization time of PNA lectin were investigated by EIS. 
Since developed system is considered to be applied for human 
samples like throat swabs in future, physiological human pH 
and body temperature were chosen as the working conditions 
so that all the experiments were carried out at pH 7.4 and 
incubation step of N was done at 37 
o
C . 
 
 
Figure 2. Nyquist plots of developed influenza A viral 
biosensor. a.Plain AuSPE, b. AuSPE/graphene-AuNp, c. 
AuSPE/graphene-AuNp/fetuin A, d. AuSPE/graphene-
AuNp/fetuin A/N, e. AuSPE/graphene-AuNp/fetuin A/N/PNA 
lectin. The EIS procedure was set to measure the electron 
transfer resistance in the frequency range of 0.1 Hz –10 kHz at 
potential of 0.1 V and 10 mM K3[Fe(CN)6]/K4[Fe(CN)6] (in 
pH:7.4, 0.1 M PBS) was used as a redox probe. 
The effect of BSA on the developed system 
 As it is well known, BSA is generally used for the blockage of 
unspecific interaction on the electrode surface, after the 
immobilization of the analyte. However, even for this step, it 
has to be waited for a period of time for the completeness of 
the attachment of BSA. In order to observe this effect, 
developed influenza A biosensor was fabricated in the 
presence of BSA, in the absence of BSA and with the 
simultaneous immobilization of fetuin A at the same time. All 
these steps were monitored by EIS under the previously 
mentioned working conditions. The obtained EIS diagrams 
(Supporting Information, Fig. S1.) demonstrate that for our 
system there isn’t any necessity for BSA addition which means 
that, there is no unspecific binding during the fabrication of 
the developed influenza A biosensor. Also by eliminating the 
addition of BSA, the preparation procedure of biosensor is 
shortened and as a result, the practicality of the fabrication 
procedure has been increased. In conclusion, no BSA 
attachment onto the electrode surface was done for the future 
experiments.  
Optimization of fetuin A immobilization time 
 Fetuin A immobilization time experiments were carried out for 
15 min, 30 min, 45 min, 60 min and 90 min incubation times 
and the results were monitored by using EIS. The obtained EIS 
diagrams were presented at the supporting information 
(Supporting Information, Fig. S2) and the excel plots in it. It can 
be seen from the Fig. S2. that the best result was obtained at 
30 min. Incubation times less than 30 min. results with lower 
difference in electrode resistance demonstrating that more 
times are needed probably for the exchange reactions 
between fetuin A amino groups and NHS to be completed. On 
the other hand, incubation times more than 30 min, resulted 
with decrease in resistance difference that might be attributed 
to the separation of non-specific bonding from the electrode 
surface. As a result, further experiments were conducted by 
using 30 min. as the optimum incubation time for fetuin A. 
The effect of PNA Lectin immobilization time 
 PNA lectin immobilization time experiments were carried out 
for 30 min, 45 min, 60 min and 90 min immobilization times by 
using EIS. The obtained EIS diagrams were presented at 
supporting information (Supporting Information, Fig. S3) and 
the excel plots were demonstrated in Fig. S3. also.  It can be 
seen from the Fig. S3. that the best result was obtained at 60 
min. Immobilization times, less than 60 min. results with lower 
difference in electrode resistance demonstrating that more 
times are needed probably for the specific binding  reactions 
between PNA lectin and galactose molecules to be completed. 
Immobilization times that lasted longer than 60 min, resulted 
with decrease in resistance difference that might be attributed 
to the falling out of PNA-galactose structure from the 
electrode surface 
11
.   
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Analytical Characteristics 
After the optimization of experimental parameters, the 
analytical characteristics were examined. For obtaining a 
calibration graph, the specific interactions between PNA lectin 
and galactose molecules that occur after the cleavages of N 
from the fetuin A were monitored. When the concentration of 
N is increased, since more fetuin A will be cleavage, more 
galactose molecules will appear and as a result, more PNA 
lectin will link to the galactose ends. All these changes were 
monitored via resistance values that were obtained from EIS 
measurements (Fig. 3.) As you can see from the Fig. 3., the 
linear range and limit of detection (LOD) values which based 
on N concentration was obtained between 10
-8
 U/mL and 10
-1
 
U/mL with the equations of y=2746x+31.69 (R
2
=0.99) and  1 x 
10
-8 
U/mL, (stated by brand that 7.9 units/mg solid) 
respectively. Relative standard deviation (R.S.D) value was 
calculated for 10
-5
 U/mL N (n=3) and found as 3.23%. For the 
comparison, obtained analytical characteristics values of 
developed electrochemical biosensor were compared with  
influenza A virus enzyme-linked immunosorbent (ELISA) assay 
results in literature. These ELISA assays relied on the N activity 
or antibody-antigen interaction. From these ELISA assays LOD 
values such as 0.7 ng/mL antigen 
53
, 33 ng/mL antigen 
53
, 0.5 
ng/mL protein 
54
 and 10
2
-10
3
  Tissue Culture Infectious Dose 50% 
(TCID50)
55 
can be seen. From these results it is obvious that 
developed sensor is sensitive enough. On the other hand 
considering rapidity and practicality, it can be said that developed 
electrochemical biosensor could definitely offer better 
performances.  
 
Figure 3. Nyquist plots of different concentration of N;  a)10
-
8
U/mL, b)2x10
-8
U/mL, c)10
-6
U/mL, d)10
-5
U/mL, e)10
-3
U/mL, 
f)10
-2
U/mL and g)10
-1
U/mL; which were used for calibration 
graph and h)the calibration graph of developed 
electrochemical influenza virus A biosensor. 
Sample application and control studies 
Evaluation of ELLA results  
 We developed the electrochemical influenza virus A biosensor 
which based on N activity. Therefore, before we applied 
developed electrochemical influenza virus A biosensor  for the 
real H9N2 influenza type A virus detection, ELLA experiment 
was carried out to demonstrate that isolated H9N2 influenza 
type A virus is active according to N (Supporting Information, 
Fig. S4). Moreover, ELLA measurements were carried out with 
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control group to demonstrate that control group is not active 
according to N. For this purpose, the ELLA results of H9N2 virus 
and control group were compared with the ELLA results of 
standard N. According ELLA results, LOD value of N was found 
as 6.52x10
-6
 U/mL.  As a result, we also supported the accuracy 
and sensitivity of the developed influenza virus A biosensors 
working principle with the ELLA using the same method. 
Evaluation of EIS results 
On the other hand, developed and optimized influenza virus A 
biosensor was applied for real virus detection, H9N2, that was 
prepared according to the procedure given in experimental 
part. For this purpose, during the fabrication of 
electrochemical influenza virus A biosensor, H9N2 influenza 
virus A sample was used instead of N. After that, in order to 
determine the N activity of H9N2 influenza virus, PNA lectin 
immobilization step was done.  
 The control study was also carried out by using uninfected egg 
sample (allantoic fluid). It can be seen from the Fig. 4. that the 
developed electrochemical influenza biosensor detects 
influenza A virus selectively. 
 
Figure 4. Nyquist plots for A) 64 UHA H9N2 influenza virus, B) 
control group by using developed electrochemical influenza 
virus A.  
Conclusions 
Another novel and effective electrochemical influenza A 
biosensor based on graphene-Au modified Au-SPE has been 
developed. This work is the continuation of our previous work 
where working principle relies on the measurement of N 
activity 
14
. From the LOD values, it is obvious that with 
developed electrochemical influenza A biosensor more 
sensitive results were obtained compared to ELLA assay. We 
believe that, the wide linear range and sensitive results from 
real influenza A sample (H9N2) analysis, increase the potential 
of usage of our system as a point of care tool for the diagnosis 
of influenza virus A in the future 
56
.  
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